These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33216394)

  • 1. Meta-analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy.
    Basu-Ray I; Khanra D; Shah SK; Mukherjee A; Char SV; Jain B; Bunch TJ; Gold M; Adeboye AA; Saeed M
    Pacing Clin Electrophysiol; 2021 Jan; 44(1):54-62. PubMed ID: 33216394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter Ablation for Ventricular Tachycardia in Ischaemic Versus Non-Ischaemic Cardiomyopathy: A Systematic Review and Meta-Analysis.
    Kanagaratnam A; Virk SA; Pham T; Anderson RD; Turnbull S; Campbell T; Bennett R; Thomas SP; Lee G; Kumar S
    Heart Lung Circ; 2022 Aug; 31(8):1064-1074. PubMed ID: 35643798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia.
    Nakahara S; Tung R; Ramirez RJ; Michowitz Y; Vaseghi M; Buch E; Gima J; Wiener I; Mahajan A; Boyle NG; Shivkumar K
    J Am Coll Cardiol; 2010 May; 55(21):2355-65. PubMed ID: 20488307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the arrhythmogenic substrate for ventricular tachycardia in patients with ischemic vs non-ischemic cardiomyopathy - insights from high-density, multi-electrode catheter mapping.
    Kotake Y; Nalliah CJ; Campbell T; Bennett RG; Turnbull S; Kumar S
    J Interv Card Electrophysiol; 2023 Jan; 66(1):5-14. PubMed ID: 34787768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm.
    Kumar S; Fujii A; Kapur S; Romero J; Mehta NK; Tanigawa S; Epstein LM; Koplan BA; Michaud GF; John RM; Stevenson WG; Tedrow UB
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):56-67. PubMed ID: 27781325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocardial substrate mapping for monomorphic ventricular tachycardia ablation in ischemic and non-ischemic cardiomyopathy.
    Fukuzawa K; Yoshida A; Kubo S; Takano T; Kiuchi K; Kanda G; Takami K; Kumagai H; Torii S; Takami M; Yokoyama M; Hirata K
    Kobe J Med Sci; 2008 Jul; 54(2):E122-35. PubMed ID: 18772614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease.
    Kumar S; Romero J; Mehta NK; Fujii A; Kapur S; Baldinger SH; Barbhaiya CR; Koplan BA; John RM; Epstein LM; Michaud GF; Tedrow UB; Stevenson WG
    Heart Rhythm; 2016 Oct; 13(10):1957-63. PubMed ID: 27392945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complication rates following ventricular tachycardia ablation in ischaemic and non-ischaemic cardiomyopathies: a systematic review.
    Ding WY; Pearman CM; Bonnett L; Adlan A; Chin SH; Denham N; Modi S; Todd D; Hall MCS; Mahida S
    J Interv Card Electrophysiol; 2022 Jan; 63(1):59-67. PubMed ID: 33512605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy.
    Tung R; Michowitz Y; Yu R; Mathuria N; Vaseghi M; Buch E; Bradfield J; Fujimura O; Gima J; Discepolo W; Mandapati R; Shivkumar K
    Heart Rhythm; 2013 Apr; 10(4):490-8. PubMed ID: 23246598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Endocardial-Epicardial Versus Endocardial Catheter Ablation Alone for Ventricular Tachycardia in Structural Heart Disease: A Systematic Review and Meta-Analysis.
    Romero J; Cerrud-Rodriguez RC; Di Biase L; Diaz JC; Alviz I; Grupposo V; Cerna L; Avendano R; Tedrow U; Natale A; Tung R; Kumar S
    JACC Clin Electrophysiol; 2019 Jan; 5(1):13-24. PubMed ID: 30678778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image Integration to Guide Catheter Ablation in Scar-Related Ventricular Tachycardia.
    Yamashita S; Sacher F; Mahida S; Berte B; Lim HS; Komatsu Y; Amraoui S; Denis A; Derval N; Laurent F; Sermesant M; Montaudon M; Hocini M; Haïssaguerre M; Jaïs P; Cochet H
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):699-708. PubMed ID: 26918883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can ventricular tachycardia non-inducibility after ablation predict reduced ventricular tachycardia recurrence and mortality in patients with non-ischemic cardiomyopathy? A meta-analysis of twenty-four observational studies.
    Hu J; Zeng S; Zhou Q; Zhu W; Xu Z; Yu J; Hong K
    Int J Cardiol; 2016 Nov; 222():689-695. PubMed ID: 27521538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy with near-normal left ventricular ejection fraction.
    Bennett RG; Campbell T; Kotake Y; Turnbull S; Kumar S
    Heart Rhythm; 2022 Jan; 19(1):51-60. PubMed ID: 34597769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Ventricular Tachycardia Circuit Between Patients With Ischemic and Nonischemic Cardiomyopathies: Detailed Characterization by Entrainment.
    Shirai Y; Liang JJ; Santangeli P; Arkles JS; Schaller RD; Supple GE; Nazarian S; Garcia FC; Lin D; Dixit S; Callans DJ; Marchlinski FE; Frankel DS
    Circ Arrhythm Electrophysiol; 2019 Jul; 12(7):e007249. PubMed ID: 31296041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epicardial ventricular tachycardia in ischemic cardiomyopathy: Prevalence, electrophysiological characteristics, and long-term ablation outcomes.
    Hayashi T; Liang JJ; Muser D; Shirai Y; Enriquez A; Garcia FC; Supple GE; Schaller RD; Frankel DS; Lin D; Nazarian S; Zado ES; Arkles JS; Dixit S; Callans DJ; Marchlinski FE; Santangeli P
    J Cardiovasc Electrophysiol; 2018 Nov; 29(11):1530-1539. PubMed ID: 30230120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia.
    Komatsu Y; Daly M; Sacher F; Cochet H; Denis A; Derval N; Jesel L; Zellerhoff S; Lim HS; Jadidi A; Nault I; Shah A; Roten L; Pascale P; Scherr D; Aurillac-Lavignolle V; Hocini M; Haïssaguerre M; Jaïs P
    J Am Coll Cardiol; 2014 Apr; 63(14):1416-26. PubMed ID: 24486269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Number of Oral Antiarrhythmic Drug Failures Before Referral on Outcomes Following Catheter Ablation of Ventricular Tachycardia.
    Romero J; Stevenson WG; Fujii A; Kapur S; Baldinger SH; Mehta NK; John RM; Michaud GF; Epstein LM; Koplan BA; Tedrow UB; Kumar S
    JACC Clin Electrophysiol; 2018 Jun; 4(6):810-819. PubMed ID: 29929675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of sex on clinical, procedural characteristics and outcomes of catheter ablation for ventricular arrhythmias according to underlying heart disease.
    Pham T; Bennett R; Kanawati J; Campbell T; Turnbull S; Thomas SP; Kumar S
    J Interv Card Electrophysiol; 2023 Jan; 66(1):203-213. PubMed ID: 35353320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter Ablation of VT in Non-Ischaemic Cardiomyopathies: Endocardial, Epicardial and Intramural Approaches.
    Bhaskaran A; Tung R; Stevenson WG; Kumar S
    Heart Lung Circ; 2019 Jan; 28(1):84-101. PubMed ID: 30385114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study.
    Dinov B; Fiedler L; Schönbauer R; Bollmann A; Rolf S; Piorkowski C; Hindricks G; Arya A
    Circulation; 2014 Feb; 129(7):728-36. PubMed ID: 24211823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.